Viral resistance patterns selected by antiretroviral drugs and their potential to guide treatment choice
- 1 August 1997
- journal article
- Published by Taylor & Francis in Expert Opinion on Investigational Drugs
- Vol. 6 (8) , 943-964
- https://doi.org/10.1517/13543784.6.8.943
Abstract
Massive viral turnover and reverse transcriptase’s high error rate create the potential for drug-resistant viral variants to appear rapidly under the selective pressure of antiretroviral therapy. Loss of antiviral effect in treatment-adherent persons is most commonly coincident with the appearance of viral mutants with reduced drug sensitivity. Thus, detection of viral resistance may represent an early marker of therapy failure. Similarly, control of viral replication in the plasma compartment, as defined by plasma viral load below the levels of assay quantification, is associated with a sustained therapeutic response and delayed development of viral resistance. Information on patterns of resistance to and cross-resistance between antiretroviral agents is increasingly well characterised and represents an important consideration when deciding how to combine and/or sequence antiretrovirals to achieve optimal antiviral effects. Given the limited number of antiretrovirals presently available or in advanced de...Keywords
This publication has 131 references indexed in Scilit:
- Perspective: Research Highlights at the Albert Einstein College of Medicine Center for AIDS Research: Approaches to Control Drug Resistance in HIV: The Role of Increased Polymerase FidelityAIDS Research and Human Retroviruses, 1996
- Treatment with Lamivudine, Zidovudine, or Both in HIV-Positive Patients with 200 to 500 CD4+ Cells per Cubic MillimeterNew England Journal of Medicine, 1995
- Clinical isolates of HIV-1 contain few pre-existing proteinase inhibitor resistance-conferring mutationsBiochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology, 1995
- Glutamine 151 participates in the substrate dNTP binding function of HIV-1 reverse transcriptaseBiochemistry, 1995
- In vivo emergence of HIV-1 variants resistant to multiple protease inhibitorsNature, 1995
- Reduction Of The In Vitro Activity Of A77003, An Inhibitor Of Human Immunodeficiency Virus Protease, By Human Serum 1 Acid GlycoproteinThe Journal of Infectious Diseases, 1995
- Genotypic And Phenotypic Analysis Of Human Immunodeficiency Virus Type 1 Isolates From Patients On Prolonged Stavudine TherapyThe Journal of Infectious Diseases, 1994
- Correlates of zidovudine phosphorylation with markers of HIV disease progression and drug toxicityAIDS, 1994
- Identification of the nucleotide binding site of HIV-1 reverse transcriptase using dTTP as a photoaffinity labelBiochemistry, 1993
- Development and significance of zidovudine resistance in children infected with human immunodeficiency virusThe Journal of Pediatrics, 1993